Value (symbol) . | Data . |
---|---|
Admission CRE positivity fraction (a) | 0.206 |
Cross-sectional facility CRE positivity fraction (f) | 0.458 |
CRE clinical detection rate per 1000 patient days (d) | 3.7 |
CRE BSI onset rate per 1000 patient days (b) | 0.9 |
Inpatient mortality rate per admission (m) | 0.215 |
Days of stay: mean; 25th, 50th, 75th percentiles | 33.8; 16, 28, 43 |
Value (symbol) . | Data . |
---|---|
Admission CRE positivity fraction (a) | 0.206 |
Cross-sectional facility CRE positivity fraction (f) | 0.458 |
CRE clinical detection rate per 1000 patient days (d) | 3.7 |
CRE BSI onset rate per 1000 patient days (b) | 0.9 |
Inpatient mortality rate per admission (m) | 0.215 |
Days of stay: mean; 25th, 50th, 75th percentiles | 33.8; 16, 28, 43 |
When calibrating our model to the positivity fraction data, we assumed the test sensitivity was 0.85, such that the actual CRE importation rate from admissions was and the cross-sectional prevalence of CRE carriers was .
Value (symbol) . | Data . |
---|---|
Admission CRE positivity fraction (a) | 0.206 |
Cross-sectional facility CRE positivity fraction (f) | 0.458 |
CRE clinical detection rate per 1000 patient days (d) | 3.7 |
CRE BSI onset rate per 1000 patient days (b) | 0.9 |
Inpatient mortality rate per admission (m) | 0.215 |
Days of stay: mean; 25th, 50th, 75th percentiles | 33.8; 16, 28, 43 |
Value (symbol) . | Data . |
---|---|
Admission CRE positivity fraction (a) | 0.206 |
Cross-sectional facility CRE positivity fraction (f) | 0.458 |
CRE clinical detection rate per 1000 patient days (d) | 3.7 |
CRE BSI onset rate per 1000 patient days (b) | 0.9 |
Inpatient mortality rate per admission (m) | 0.215 |
Days of stay: mean; 25th, 50th, 75th percentiles | 33.8; 16, 28, 43 |
When calibrating our model to the positivity fraction data, we assumed the test sensitivity was 0.85, such that the actual CRE importation rate from admissions was and the cross-sectional prevalence of CRE carriers was .
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.